Immunic, Inc.IMUXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-85.97M
↓ 47% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-58.68M
Historical baseline
PeriodValueYoY Change
2025$-85.97M-1.1%
2024$-85.03M-19.5%
2023$-71.16M-9.1%
2022$-65.26M+21.7%
2021$-83.30M-80.0%
2020$-46.27M-61.8%
2019$-28.60M+34.6%
2018$-43.76M-6.5%
2017$-41.08M-13.1%
2016$-36.33M-